Patent · US Expired

Production of an immunovariant strain of Eimeria maxima contributes to strain cross-protection with other Eimeria maximas

US6969602B1 · kind B1 · utility

2Cited by

0References

2Claims

0Family size

Assignees

The United States of America, as represented by the Secretary of the Agriculture · US
UNIVERSITY OF GUELPH · CA

Inventors

Harry D. Danforth · Severn, US
M. Aggie Fernando · Waterloo, CA
John R. Barta · Guelph, CA

Key dates

Filing date	Apr 20, 2001
Grant date	Nov 29, 2005
Priority date	—
Expiry date	Apr 20, 2021

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/822
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An immunovariant strain of Eimeria maxima was isolated. Vaccines incorporating the immunovariant strain are effective in eliciting immunological protection against coccidial infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.